NSC305787 is primarily investigated for its potential in cancer research, particularly as a chemotherapeutic agent. It has shown promise in targeting specific cancer cell lines, inhibiting their proliferation, and inducing apoptosis. Researchers are exploring its efficacy in combination therapies to enhance treatment outcomes and reduce drug resistance. Additionally, its mechanism of action is being studied to understand its interaction with cellular pathways, which could lead to the development of novel anticancer drugs. Beyond oncology, NSC305787 is also being examined for its role in other diseases where cell cycle regulation is critical.